Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-03-02

Clinical Trial Update: Evaluation of the Efficacy and Safety of Solabegron Tablets for Treatment of Overactive Bladder in Adult Women [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of solabegron tablets in adult women with overactive bladder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Solabegron (solabegron)

Snippet

Sponsor: Velicept Therapeutics, Inc. | Conditions: Overactive Bladder | Phase 2 | Status: COMPLETED